Details for Patent: 12,678,504

« Back to Dashboard

Which drugs does patent 12,678,504 protect, and when does it expire?

Patent 12,678,504 protects XELSTRYM and is included in one NDA.

This patent has eleven patent family members in nine countries.

Summary for Patent: 12,678,504

Title:	Stable transdermal amphetamine compositions and methods of manufacture
Abstract:	Described are transdermal drug delivery compositions comprising amphetamine, methods of making transdermal drug delivery compositions comprising amphetamine, and therapeutic methods of using them. In specific embodiments, the compositions are free of components with moieties that are reactive with amphetamine. In specific embodiments, the compositions are manufactured using solvents free of components with moieties that are reactive with amphetamine. Therapeutic methods using the compositions also are described.
Inventor(s):	Viet Nguyen, Jun Liao, Prashant Patel
Assignee:	Noven Pharmaceuticals Inc
Application Number:	US17/836,883
Patent Claim Types: see list of patent claims	Use; Composition; Delivery;

Drugs Protected by US Patent 12,678,504

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Noven Pharms Inc	XELSTRYM	dextroamphetamine	SYSTEM;TRANSDERMAL	215401-001	Mar 22, 2022		RX	Yes	No	12,678,504		Y			METHOD OF TRANSDERMALLY ADMINISTERING DEXTROAMPHETAMINE
Noven Pharms Inc	XELSTRYM	dextroamphetamine	SYSTEM;TRANSDERMAL	215401-002	Mar 22, 2022		RX	Yes	No	12,678,504		Y			METHOD OF TRANSDERMALLY ADMINISTERING DEXTROAMPHETAMINE
Noven Pharms Inc	XELSTRYM	dextroamphetamine	SYSTEM;TRANSDERMAL	215401-003	Mar 22, 2022		RX	Yes	No	12,678,504		Y			METHOD OF TRANSDERMALLY ADMINISTERING DEXTROAMPHETAMINE

International Family Members for US Patent 12,678,504

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	095260
Australia	2014235057
Canada	2905907